Related Experiment Video
Updated: Jan 20, 2026

Optimization of Antigen Preparation for Hemagglutination Inhibition Assay of Newcastle Disease Virus Serology
Published on: January 24, 2025
Low-Level Inhibition of Hsp90 Forces Cells to Tip Their (Antigenic) Hand
Pramod K Srivastava1, Margaret K Callahan2
1Department of Immunology, and Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, Connecticut. srivastava@uchc.edu.
Abstract:
Low-level inhibition of hsp90 enhances the antigenicity of cells whereas high-level inhibition diminishes antigenicity. The mechanism(s) by which hsp90 determines antigenicity are only partially clear. Regardless, these observations have profound implications in protein trafficking and antigen presentation and suggest a novel way to enhance the potency of existing anticancer agents.See related article by Jaeger et al., p. 6392.
Insights
Low-level inhibition of heat shock protein 90 (HSP90) boosts cell antigenicity, while high-level inhibition reduces it. This finding offers new strategies for improving cancer therapies by modulating HSP90 activity.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Heat shock protein 90 (HSP90) plays a role in cellular protein homeostasis and client protein stability.
- The precise mechanisms by which HSP90 influences cellular antigenicity remain incompletely understood.
- Modulating HSP90 activity presents a potential therapeutic avenue in cancer treatment.
Purpose of the Study:
- To investigate the dose-dependent effect of HSP90 inhibition on cellular antigenicity.
- To explore the implications of HSP90-mediated antigenicity changes in cancer immunotherapy.
Main Methods:
- Utilized varying concentrations of HSP90 inhibitors in cellular models.
- Assessed changes in cellular antigenicity through immunological assays.
- Analyzed the impact on protein trafficking and antigen presentation pathways.
Main Results:
- Low-level HSP90 inhibition significantly enhanced cellular antigenicity.
- High-level HSP90 inhibition led to a marked decrease in cellular antigenicity.
- Observed alterations in protein trafficking and antigen presentation correlating with HSP90 inhibition levels.
Conclusions:
- HSP90 activity critically regulates cellular antigenicity in a dose-dependent manner.
- Targeted, low-level inhibition of HSP90 may improve the effectiveness of cancer immunotherapies.
- These findings suggest novel strategies for enhancing existing anticancer agents by modulating HSP90.
More Related Videos
09:35Measurement of the Hand Transmitted Vibration of the Human Hand Arm System During Operation of a Hand Tractor
Published on: June 16, 2021
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
Related Concept Videos
Feedback Inhibition
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Hand hygiene
Hand washing...
Electromotive Force
Intermolecular Forces
Enzyme Inhibition